Swipe om te navigeren naar een ander artikel
This pilot randomized controlled trial (RCT) investigated benefits of omega-3 fatty acid supplementation and Individual-Family Psychoeducational Psychotherapy (PEP; a family-focused, cognitive-behavioral therapy) for behavior problems among youth with depression. Participants aged 7–14 with DSM-IV-TR depressive disorders (N = 72; 56.9 % male) were randomized to 1 of 4 treatment conditions: PEP + omega-3, PEP monotherapy (with pill placebo), omega-3 monotherapy, or placebo (without active intervention). At screen, baseline, and 2, 4, 6, 9, and 12 weeks post-baseline, parents completed the SNAP-IV, which assesses attention-deficit/hyperactivity disorder symptoms, oppositional defiant disorder symptoms, and overall behavior problems. At screen, baseline (randomization), 6 and 12 weeks, parents completed the Eyberg Child Behavior Inventory (ECBI), which includes Intensity and Problem scales for child behavior problems. Youth who had a completed SNAP-IV or ECBI for at least two assessments during treatment (n = 48 and 38, respectively) were included in analyses of the respective outcome. ClinicalTrials.gov.:NCT01341925. Linear mixed effects models indicated a significant effect of combined PEP + omega-3 on SNAP-IV Total (p = 0.022, d = 0.80) and Hyperactivity/Impulsivity trajectories (p = 0.008, d = 0.80), such that youth in the combined group saw greater behavioral improvement than those receiving only placebo. Similarly, youth in combined treatment had more favorable ECBI Intensity trajectories than youth who received no active treatment (p = 0.012, d = 1.07). Results from this pilot RCT suggest that combined PEP + omega-3 is a promising treatment for co-occurring behavior symptoms in youth with depression.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Ahn, J., Ahn, H. S., Cheong, J. H., & dela Pena, I. (2016). Natural product-derived treatments for attention-deficit/hyperactivity disorder: safety, efficacy, and therapeutic potential of combination therapy. Neural Plasticity. doi: 10.1155/2016/1320423.
American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR (4th ed., text revision ed.). Washington, DC: American Psychiatric Association.
Axelson, D., Birmaher, B. J., Brent, D., Wassick, S., Hoover, C., Bridge, J., & Ryan, N. (2003). A preliminary study of the kiddie schedule for affective disorders and schizophrenia for school-age children mania rating scale for children and adolescents. Journal of Child and Adolescent Psychopharmacology, 13, 463–470. doi: 10.1089/104454603322724850. CrossRefPubMed
Birmaher, B., Brent, D., & the AACAP Work Group on Quality Issues (2007). Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 1503–1526. doi: 10.1097/chi.0b013e318145ae1c. CrossRefPubMed
Bloch, M. H., & Qawasmi, A. (2011). Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 50, 991–1000. doi: 10.1016/j.jaac.2011.06.008. CrossRefPubMedPubMedCentral
Bos, D. J., Oranje, B., Veerhoek, E. S., Van Diepen, R. M., Weusten, J. M., Demmelmair, H., et al. (2015). Reduced symptoms of inattention after dietary omega-3 fatty acid supplementation in boys with and without attention deficit/hyperactivity disorder. Neuropsychopharmacology, 40, 2298–2306. doi: 10.1038/npp.2015.73. CrossRefPubMedPubMedCentral
Boylan, K., MacPherson, H. A., & Fristad, M. A. (2013). Examination of disruptive behavior outcomes and moderation in a randomized psychotherapy trial for mood disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 52, –708. doi: 10.1016/j.jaac.2013.04.014.
Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., et al. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA, 297, 1683–1696. doi: 10.1001/jama.297.15.1683. CrossRefPubMed
Bussing, R., Fernandez, M., Harwood, M., Hou, W., Garvan, C. W., Eyberg, S. M., & Swanson, J. M. (2008). Parent and teacher SNAP-IV ratings of attention deficit hyperactivity disorder symptoms psychometric properties and normative ratings from a school district sample. Assessment, 15, 317–328. doi: 10.1177/1073191107313888. CrossRefPubMedPubMedCentral
Chambers, W. J., Puig-Antich, J., Hirsch, M., Paez, P., Ambrosini, P. J., Tabrizi, M. A., & Davies, M. (1985). The assessment of affective disorders in children and adolescents by semistructured interview: test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version. Archives of General Psychiatry, 42, 696–702. doi: 10.1001/archpsyc.1985.01790300064008. CrossRefPubMed
Clarke, G. N., Rohde, P., Lewinsohn, P. M., Hops, H., & Seeley, J. R. (1999). Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 272–279. doi: 10.1097/00004583-199903000-00014. CrossRefPubMed
Clayton, E. H., Hanstock, T. L., Hirneth, S. J., Kable, C. J., Garg, M. L., & Hazell, P. L. (2009). Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. European Journal of Clinical Nutrition, 63, 1037–1040. doi: 10.1038/ejcn.2008.81. CrossRefPubMed
Costello, E. J., Erkanli, A., & Angold, A. (2006). Is there an epidemic of child or adolescent depression? Journal of Child Psychology and Psychiatry, 47, 1263–1271. doi: 10.1111/j.1469-7610.2006.01682.x.
Diamond, G. S., Reis, B. F., Diamond, G. M., Siqueland, L., & Isaacs, L. (2002). Attachment-based family therapy for depressed adolescents: a treatment development study. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1190–1196. doi: 10.1097/00004583-200210000-00008. CrossRefPubMed
Eyberg, S. M., & Pincus, D. (1999). Eyberg child behavior inventory & sutter-eyberg student behavior inventory-revised: professional manual. Odessa: Psychological Assessment Resources.
Fristad, M. A., Goldberg-Arnold, J. S., & Leffler, J. M. (2011). Psychotherapy for children with bipolar and depressive disorders. New York: Guilford Press.
Fristad, M. A., Young, A. S., Vesco, A. T., Nader, E. S., Healy, K. Z., Gardner, W., et al. (2015). A randomized controlled trial of individual family psychoeducational psychotherapy & omega-3 fatty acids in youth with subsyndromal bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 25, 764–774. doi: 10.1089/cap.2015.0132. CrossRefPubMedPubMedCentral
Fristad, M. A., Vesco, A. T., Young, A. S., Healy, K. Z., Nader, E. S., Gardner, W.,… Arnold, L. E. (2016). Pilot RCT of omega-3 and individual-family psychoeducational psychotherapy for children and adolescents with depression. Journal of Clinical Child and Adolescent Psychology (in press).
Gillies, D., Sinn, J., Lad, S. S., Leach, M. J., & Ross, M. J. (2012). Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database of Systematic Reviews, 7, CD007986. doi: 10.1002/14651858.CD007986.pub2.
Jacobs, R. H., Becker-Weidman, E. G., Reinecke, M. A., Jordan, N., Silva, S. G., Rohde, P., & March, J. S. (2010). Treating depression and oppositional behavior in adolescents. Journal of Clinical Child and Adolescent Psychology, 39, 559–567. doi: 10.1080/15374416.2010.486318. CrossRefPubMedPubMedCentral
Kaufman, J., Birmaher, B., Brent, D., Rao, U., Flynn, C., Moreci, P., et al. (1997). Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 980–988. doi: 10.1097/00004583-199707000-00021. CrossRefPubMed
Knapp, M., McCrone, P., Fombonne, E., Beecham, J., & Wostear, G. (2002). The Maudsley long-term follow-up of child and adolescent depression 3. Impact of comorbid conduct disorder on service use and costs in adulthood. British Journal of Psychiatry, 180, 19–23. doi: 10.1192/bjp.180.1.19. CrossRefPubMed
Pliszka, S., & AACAP Work Group on Quality Issues (2007). Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 894–921. doi: 10.1097/chi.0b013e318054e724. CrossRefPubMed
Raine, A., Portnoy, J., Liu, J., Mahoomed, T., & Hibbeln, J. R. (2015). Reduction in behavior problems with omega-3 supplementation in children aged 8-16 years: a randomized, double-blind, placebo-controlled, stratified, parallel-group trial. Journal of Child Psychology and Psychiatry, 56, 509–520. doi: 10.1111/jcpp.12314. CrossRefPubMed
Rohde, P., Clarke, G. N., Lewinsohn, P. M., Seeley, J. R., & Kaufman, N. K. (2001). Impact of comorbidity on a cognitive-behavioral group treatment for adolescent depression. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 795–802. doi: 10.1097/00004583-200107000-00014. CrossRefPubMed
Smeets, K. C., Leeijen, A. A., van der Molen, M. J., Scheepers, F. E., Buitelaar, J. K., & Rommelse, N. N. (2015). Treatment moderators of cognitive behavior therapy to reduce aggressive behavior: a meta-analysis. European Child & Adolescent Psychiatry, 24, 255–264. doi: 10.1007/s00787-014-0592-1. CrossRef
Sonuga-Barke, E. J., Brandeis, D., Cortese, S., Daley, D., Ferrin, M., Holtmann, M., et al. (2013). Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. American Journal of Psychiatry, 170, 275–289. doi: 10.1176/appi.ajp.2012.12070991. CrossRefPubMed
Steiner, H., Remsing, L., & AACAP Work Group on Quality Issues (2007). Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 126–141. doi: 10.1097/01.chi.0000246060.62706.af. CrossRefPubMed
Swanson, J. M. (1992). School-based assessments and interventions for ADD students. Irvine: KC Publishing.
Swanson, J. M., Kraemer, H. C., Hinshaw, S. P., Arnold, L. E., Conners, C. K., Abikoff, H. B., et al. (2001). Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 168–179. doi: 10.1097/00004583-200102000-00011. CrossRefPubMed
Tammam, J. D., Steinsaltz, D., Bester, D. W., Semb-Andenaes, T., & Stein, J. F. (2016). A randomised double-blind placebo-controlled trial investigating the behavioural effects of vitamin, mineral and n-3 fatty acid supplementation in typically developing adolescent schoolchildren. British Journal of Nutrition, 115, 361–373. doi: 10.1017/S0007114515004390. CrossRefPubMed
U.S. Food and Drug Administration (2004). FDA launches a multi-pronged strategy to strengthen safeguards for children treated with antidepressant medications. Silver Spring: U.S. Food and Drug Administration.
- Psychoeducational Psychotherapy and Omega-3 Supplementation Improve Co-Occurring Behavioral Problems in Youth with Depression: Results from a Pilot RCT
Andrea S. Young
L. Eugene Arnold
Hannah L. Wolfson
Mary A. Fristad
- Springer US